Tonicity affects red blood cells by altering their volume through osmotic pressure differences. Hypertonic solutions cause cell shrinkage, hypotonic solutions lead to swelling and potential lysis, while isotonic solutions maintain stability. Pharmaceutical formulations for IV administration must be isotonic to avoid hemolysis or crenation, ensuring safe and effective delivery .

Buffer capacity is the measure of a buffer solution's resistance to pH change upon the addition of acid or base. It is influenced by the concentration of the buffer components; higher concentrations offer greater capacity. This property is pivotal for maintaining the desired pH level in solutions, particularly in pharmaceuticals, ensuring consistent drug performance and stability .

pH is critical in pharmaceutical formulations as it affects drug solubility, stability, and dissolution rate. A drug's ionization state, influenced by pH, can alter its absorption and bioavailability. Ensuring optimal pH prevents degradation and maintains efficacy, crucial for formulations with narrow therapeutic windows .

Ligands act as electron pair donors in complexation, binding to metal centers and stabilizing the structure. They are classified based on their denticity - the number of donor sites they possess. Monodentate ligands bind through one donor atom, whereas bidentate ligands engage two. Polydentate or chelating ligands, such as EDTA, use several donor sites, forming more stable complexes by creating multiple coordination points .

Clathrates are cage-like structures in which one molecule is trapped within another's lattice. They impact pharmaceutical formulations by altering the solubility and stability of the included compounds. This can be harnessed to enhance shelf-life and control the release of active pharmaceutical ingredients, improving formulation efficiency .

Buffers are vital in maintaining stable pH levels in biological and pharmaceutical systems, crucial for drug stability and enzymatic activity. Effective buffers resist significant pH changes upon acid or base addition, possess appropriate pKa values near the environment's pH, and have sufficient buffer capacity to counteract biological or chemical changes .

Complexation benefits pharmaceutical formulations by improving drug solubility, stability, and bioavailability. This process involves various types of complexes, including coordination complexes, which form through coordinate covalent bonds between metal ions and ligands. Chelates, a subset, involve coordination with multiple bonding sites. Other types include ionic complexes and molecular inclusion complexes, like cyclodextrins, which enhance solubility by encapsulating drug molecules .

The Henderson-Hasselbalch equation is used to estimate the pH of buffer solutions and the degree of ionization for a drug substance, influencing absorption and solubility. Its application is crucial in preparing buffer systems and optimizing drug formulation. However, limitations include its inaccuracy in non-dilute solutions and inability to predict pH shifts due to ion strength variations .

Drug-protein binding kinetics are crucial in pharmacokinetics as they dictate the free vs. bound drug fraction in plasma. A dynamically bound drug modulates its bioavailability, distribution, and elimination rates. High binding may reduce the free drug concentration, decreasing efficacy, while low affinity can risk rapid clearance or toxicity due to excess free drug in circulation .

Inclusion complexes differ as they encapsulate guest molecules entirely or partially within the host structure, such as cyclodextrins. This contrasts with simple coordination complexes where ligands attach externally. They are significant in drug delivery by improving the solubility and stability of hydrophobic drugs, enabling better bioavailability and sustained release in the body .